Los puntos clave no están disponibles para este artículo en este momento.
The U.S. pharmaceutical market has always been influenced by government. The 2022 Inflation Reduction Act is the latest policy aiming to improve access and affordability while supporting innovation.
Conti et al. (Sat,) studied this question.